IDEXX Laboratories, Inc.IDXX
Price$517.75Intrinsic value$520.010% above price

Qualitative Analysis

Business overview

Business Overview

IDEXX Laboratories, Inc. (IDXX) is a global leader in veterinary diagnostics, software, and water microbiology testing. The company operates primarily through its Companion Animal Group (CAG) segment, which provides in-clinic diagnostic analyzers, rapid assay test kits, reference laboratory services, and cloud-based practice management systems (PIMS) like ezyVet and Neo. IDEXX also serves water quality testing and livestock/poultry diagnostics markets. The company's business model is highly recurring, driven by consumable reagents and test kits generated from its expanding global premium instrument installed base.

Research as of 5 Jun 2026

Sources: 3

Strategic Initiatives

Growth programs, investments, and their expected impact

AI-assisted
Catalyst cardiac-diagnostics expansionInnovation

IDEXX is adding the quantitative, dual-species Catalyst proBNP Test to its connected point-of-care and reference-laboratory cardiac portfolio, with North American availability beginning in October 2026 and international regions to follow.

Sign in / Sign up to read more
Integrated veterinary cancer diagnosticsGrowth

IDEXX is expanding the Cancer Dx Panel with canine mast-cell-tumor detection while broadening fine-needle-aspiration cytology on the inVue Dx analyzer, linking preventive reference-laboratory screening with rapid in-clinic assessment.

Sign in / Sign up to read more
Connected diagnostics, software, and artificial-intelligence pipelineTransformation

IDEXX's 2026 Investor Day strategy emphasized future MultiCue Dx development, further inVue Dx and Catalyst menu expansion, major-disease-franchise testing, customer-facing software, artificial intelligence, commercial investment, and increased diagnostic utilization.

Sign in / Sign up to read more
Sources: 3

Mergers, Acquisitions & Partnerships

Recent deals and strategic collaborations

AI-assisted

Recent Acquisitions

Tecta-PDS$0Complete
Announced 1 Aug 2022

Acquisition of Tecta-PDS, a Kingston-based provider of automated water testing solutions, to strengthen IDEXX's Water quality products segment.

Financial impact: Immaterial to overall consolidated revenues but expands the technological capabilities of the Water segment.

Sign in / Sign up to read more

Strategic Partnerships

American College of Veterinary Internal Medicine (ACVIM)Educational Collaboration

High

Terms: Complimentary educational resources provided to ACVIM residents via the SpringBoard platform.

Sign in / Sign up to read more
World Small Animal Veterinary Association (WSAVA)Clinical Webinar Series

Medium

Terms: IDEXX acts as a Silver Partner to deliver expert-led diagnostic webinars to the global veterinary community.

Sign in / Sign up to read more
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.